Skip to main content
OpenTrials

Clinical trial condition

Pasteurellaceae Infections

Explore clinical trials studying Pasteurellaceae Infections. Study availability and eligibility vary by location and protocol.

162 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Pasteurellaceae Infections trial results

Completed

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

NCT02096263

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
  • GSK Investigational Site Anaheim, California, United States
  • GSK Investigational Site Daly City, California, United States
View all 43 locations
View Trial Details
Completed

A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia

NCT02858440

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +25 more
Locations
  • GSK Investigational Site Barnaul, Russia
  • GSK Investigational Site Murmansk, Russia
  • GSK Investigational Site Saint Petersburg, Russia
  • GSK Investigational Site Tomsk, Russia
View Trial Details
Completed

Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants

NCT01616459

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations
  • GSK Investigational Site Benešov, Czechia
  • GSK Investigational Site Děčín, Czechia
  • GSK Investigational Site Domažlice, Czechia
  • GSK Investigational Site Jindřichův Hradec, Czechia
View all 42 locations
View Trial Details
Completed

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants

NCT01204658

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations
  • GSK Investigational Site Benešov, Czechia
  • GSK Investigational Site Brno, Czechia
  • GSK Investigational Site Děčín, Czechia
  • GSK Investigational Site Jindřichův Hradec, Czechia
View all 24 locations
View Trial Details

Related conditions